A Stealthy Fungal Attack Requires an Equally Clandestine Approach to Onychomycosis Treatment

Area of Science:

• Medical Mycology
• Immunology
• Dermatology

Background:

• Onychomycosis is a chronic fungal nail infection.
• It is often resistant to standard antifungal treatments, leading to low cure rates.
• The reasons for treatment failure are not fully understood.

Purpose of the Study:

• To explore the factors contributing to the ineffectiveness of antifungal therapies for onychomycosis.
• To propose a treatment strategy that addresses these contributing factors.

Main Methods:

• Review of existing evidence on onychomycosis pathophysiology and treatment outcomes.
• Analysis of immunological, microbiological, and pharmacokinetic factors affecting nail infections.

Main Results:

• Limited immune cell presence in the nail bed hinders treatment efficacy.
• Reduced local circulation impacts drug delivery to the site of infection.
• Commensal microorganisms and fungal modulation of host immune signaling may play a role.

Conclusions:

• Current antifungal treatments for onychomycosis are often insufficient due to biological barriers.
• Novel therapeutic approaches should aim to enhance both innate and adaptive immune responses.
• Synergistic strategies combining antifungals with immunomodulatory agents warrant investigation.